Medical network on December 5th - the first basis of medicare payment standard is the actual price of drug sales, so the pharmaceutical companies don't do your price wrong, if I do wrong, the price no one save you.
Social social security center of medical services in this country people management office director Duan Zheng Ming in Chinese medicine seven-time six times, President of the association of business management (expand) meeting and 30th on the development of Chinese medicine industry peak BBS speech activity
Health insurance payment standard is not a drug prices. I have been repeatedly said, the price is the market transaction, health department through the pay standards indirectly affect the price of drugs.
Drugs from pharmaceutical factory to ginseng protect people's hand, the first link is pharmacies sell medicine to the hospital, it is pure market economic activity. The second part, put the medicine prescribed to patients, hospital drug effect is to guarantee at this moment. In a recent view is not profit, I think this view is open to question, is the production of drugs as drug companies, how can't with drug profit? In the second section, ginseng protect personnel to have no money with this medicine, health care to support he can afford the medicine, the first link drugs is the commodity, the second link drug is a special commodity, is used to protect personnel to see a doctor.
So our standard is the definition of ginseng protect personnel to use medicare catalog class medicines, medical insurance fund to the designated agencies including pharmacy, medical institutions drug cost benchmark, rather than price. I often joked that the national development and reform commission to bad for the price of drugs, we people club department he2 de2 he2 ability to make the price of drugs.
We at the time of setting standards, the first to promote the market in the role of drug price formation, reduce the direct intervention of the administrative department for the formation of drug prices. Secondly, to combine the hospital and the tender of cohesion, promote medical institutions actively adopt the affordable medicines.
After the evaluation consistency and common name
We now have some drug policy deprived of medical institutions in purchasing drugs to talk about the price of rights, it is with the development of market economy is not consistent, the body is very important. The first link in traditional Chinese medicine factory sell medicine to the hospital, the body is the hospital, the government should set up a platform, release information, regulating the behavior of both sides, promote communication between drugs and costs, such as when the receivable waiting, the government should do such work. If stripped of the enthusiasm of medical institutions to reduce the price, it is hard to imagine that this policy will be successful.
I think deepen reform so difficult, in fact, reform without fully arouse the enthusiasm of hospitals and doctors, we think, will be successful? So on this aspect we want to encourage medical institutions will be able to have a mechanism to encourage medical institutions to take initiative to purchase affordable medicines.
By formulating drug payment standards for public hospital reform. There are four here to grasp the principle of:
1) guarantee basic;
2) to promote rational drug use.
3) steady progress, there is no payment standards before, still according to the existing drug prices, gradual transition;
4) to fair, open and fair, in formulating drug payment standard, if there are a lot of general name drugs have gone through the drugs quality consistency evaluation, then we can take to common name to formulate standard. If in almost all the generic name or a lot of medicine have consistency evaluation yet, so at an early stage, we suggest that according to the product name to identify the payment standard, for some special pediatric medicine, rescue medication will take in comparison to other difference.
In making payment standard, if there are a lot of general name drugs have gone through the drugs quality consistency evaluation, you can take to general called standards; If in almost all the generic name, or a lot of drugs can not evaluate the consistency, at an early stage, as defined by the brand name is the payment standard, part of the pediatric medicine, rescue medication'll take different control methods.
Difference to the hospital, drug firms need to be careful
If the hospital drug price and the payment standard is the same, then we have to pay for the standard as the foundation to pay; If payment standard is 100 pieces, the hospital drug sales price is $80, the medical insurance fund paid by the standard of 100 yuan, still more to do with the money? In principle, should be owned by the hospital. Now in some places in some exploration, such as most of the internal first turned over to the finance, fiscal, through examination, again returned to the hospital, of course, the situation here is a high and a right and a low.
If, in accordance with the principle of price difference shall be attributed to the hospital all the payment standard how to develop?
The first is based on the real price of drug sales. Attention, not just the bidding price, we require a medical institution shall submit the actual situation of drug sales, including name, specification, quantity, price and so on, this information must be give us regulators count off used to understand the real market price of the drug.
Such as shown on the sales of parameter into a hospital 1000 penicillin, he gave us an return costs 800, by definition, his inventory and 200, results when we check in to the hospital, found his inventory and 700 inside, what reason be? One possibility is that the hospital the padded accounts or bills, not so much, only 300, 800, he got to obtain social security funds. Another possibility is that bought 1000, sent 500 cigarettes, buy two give a, so the price is not the price, both sides sign the agreement when certain space, prices are still under medical entrepreneurs don't put your price so do wrong, if your price by themselves, no one save you.
Second, we should consult the bidding price, but also refer to the prices of similar products to compare with each other, with reference to the surrounding area of the price of the product.
For some innovation in medicine, we should follow the Chinese Hong Kong, Taiwan and Japan, in the end through a calculation formula to determine medicare payments standard.
In this process, we mainly some train of thought is that the required local clubs and health development planning commission established department, also have come from hospitals, drug companies, industry associations and so on various aspects on behalf of the formation of a committee, determine the local payment standard practice, including how to calculate, how to get drugs price information, how to delimit the information how to calculate the standard price.
After determine to the relevant office, by the office of the specific implementation, finally publish to the society, at the same time people club department, the national development and reform commission, who planning commission for the record. Is in general, a province to develop. Some special cases, such as the same province, geographic area is large, price difference is very big, this kind of circumstance can be entrusted by the province, determined by cities, but the methods specified plan must comply with the requirements of the province.
At the same time we roughly every two years to round out the drug adjustment, Taiwan also is such. In the process of adjustment, we want to pay the standard affect the next round of drug transaction price. I repeatedly said payment standard is not the price of drugs, but it will affect the formation of drug prices, and it is through a set of positive incentives, encourage medical should adopt the way of cheap enough to promote drug on the market price formation. |
